Prospective Cohort of Patients With Intracerebral Hemorrhage

Multicentral Observational Prospective Cohort of Patients With Spontaneous Intracerebral Hemorrhage

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06670456

Enrollment

3000

Registered

2024-11-01

Start date

2023-11-06

Completion date

2028-12-30

Last updated

2024-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Hemorrhage, Stroke, Acute

Keywords

Intracerebral Hemorrhage

Brief summary

The investigators designed a multicentral, observational, prospective cohort study to provide cortical data for risk stratification and biomarkers on early outcomes, complications, long-term neurological function, and cognitive status of spontaneous intracerebral hemorrhage patients.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosed with spontaneous intracerebral hemorrhage (ICH) through skull radiologic scans (CT or MRI); * Underwent no surgical intervention;

Exclusion criteria

* Secondary intracerebral hemorrhage (with leading cause, e.g., Moyamoya disease, arteriovenous malformation, intracranial aneurysm, tumor, brain trauma) * Pre-stroke life expectancy < 1 year for severe comorbidities (e.g., Progressive malignant tumor, severe chronic heart failure \[NYHA: III-IV\], severe chronic obstructive pulmonary disease \[III-IV\], chronic kidney disease requiring hemodialysis) * Severe dependency or incorporation to interview (e.g., pre-stroke mRS>3, severe dementia, intractable mental disease) * Unsuitable for inclusion in the study in the opinion of the investigator

Design outcomes

Primary

Measure	Time frame	Description
Neurological Function	Discharge; 3, 6, 12 months after enrollment	Assessed with modified Rankin Scale (0-6)
Mortality	Discharge; 3, 6, 12 months after enrollment	—

Secondary

Measure	Time frame	Description
Complications	Admission period; the 3, 6, 12 months after enrollment	Lately stoke, epilepsy, infections, cardiac event, ebolism.
Cognitive Status	The 3, 6, 12 months after enrollment	Assessed with Telephone Interview for Cognitive Status - Modifed scale (0-51) Chinese version

Countries

China

Contacts

Primary ContactDe-zhi Kang, MD

kdz99988@vip.sina.com86 15759413951

Backup ContactFu-xin Fu-xin, MD

lfxstudy@126.com86 13600893154

Outcome results